These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20272373)

  • 1. Tolerance to intravenously administered protein hydrolysate in severe human liver cirrhosis.
    LEWIS JH; TAYLOR FH; DAVIDSON CS
    Am J Med Sci; 1947 Dec; 214(6):656-61. PubMed ID: 20272373
    [No Abstract]   [Full Text] [Related]  

  • 2. Cirrhosis of the liver; impending hepatic coma and increased blood ammonium concentrations during protein hydrolysate infusion.
    WEBSTER LT; DAVIDSON CS
    J Lab Clin Med; 1957 Jul; 50(1):1-10. PubMed ID: 13439261
    [No Abstract]   [Full Text] [Related]  

  • 3. Time factors in the utilization of a mixture of amino acids (protein hydrolysate) and dextrose given intravenously.
    ELMAN R
    J Clin Nutr; 1953; 1(4):287-94. PubMed ID: 13061602
    [No Abstract]   [Full Text] [Related]  

  • 4. CONJUGATION OF C14-LABELLED FREE CHOLIC ACID IN LIVER HOMOGENATES OF OPERATIVE BIOPSY SPECIMENS IN MAN. II. EFFECT OF INTRAVENOUS ADMINISTRATION OF CASEIN HYDROLYSATE.
    SUNZEL H
    Acta Chir Scand; 1963 Dec; 126():605-11. PubMed ID: 14085174
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrogen retention after intravenous and oral administration of protein hydrolysate and native protein enterally.
    SAKO Y; KREMEN AJ; VARCO RL
    Proc Soc Exp Biol Med; 1948; 68(3):480-2. PubMed ID: 18884259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydrolysate therapy in the clinical picture of internal diseases].
    Al'perin PM; Melekhova OP; Zamchiĭ AA
    Probl Gematol Pereliv Krovi; 1975 Nov; 20(11):44-6. PubMed ID: 1226384
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experiences with intravenous alcohol; the postoperative use of 7.5% ethyl alcohol, 5% protein hydrolysate and 5% dextrose in 1000cc. of water.
    GRABILL FJ; HOCKMUTH LN
    Bull Georgetown Univ Med Cent; 1949; 3(3):102-5. PubMed ID: 15397530
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of active liver cirrhosis in patients maintained with amino acids intravenously as the source of protein and lipotropic substances.
    ECKHARDT RD; FALOON WW; DAVIDSON CS
    J Clin Invest; 1948 Jul; 27(4):531. PubMed ID: 18939297
    [No Abstract]   [Full Text] [Related]  

  • 9. IMPROVEMENT OF ACTIVE LIVER CIRRHOSIS IN PATIENTS MAINTAINED WITH AMINO ACIDS INTRAVENOUSLY AS THE SOURCE OF PROTEIN AND LIPOTROPIC SUBSTANCES.
    Eckhardt RD; Faloon WW; Davidson CS
    J Clin Invest; 1949 Jul; 28(4):603-14. PubMed ID: 16695717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of protein hydrolysates in glucose medium in the treatment of ascitic cirrhosis].
    BERGERON A; BELIN J; COGNET A
    Therapie; 1955; 10(5):769-75. PubMed ID: 13299233
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of cirrhosis of the liver with crude liver extract by the intravenous route.
    RAWLS WB; ANCONA VC
    Rev Gastroenterol; 1947 Oct; 14(10):685-92. PubMed ID: 20268353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of liver cirrhosis with intravenously injected liver hydrolysates].
    BOECKER W
    Med Klin; 1956 Apr; 51(15):641-5. PubMed ID: 13347887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of liver hydrolysate injected intravenously].
    REICHERT K
    Ther Ggw; 1952 Nov; 91(11):424-5. PubMed ID: 13029088
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of plasma and its preparations in liver cirrhosis and other states of protein deficiency].
    Alperin PM; Zherebetsov LA; Melikhova OP; Zamchiĭ AA; Voronina LN
    Ter Arkh; 1971 Oct; 43(10):44-7. PubMed ID: 5140951
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of protein hydrolysate administration on liver composition.
    Alston WC; Thomson RY
    Cancer Res; 1968 Apr; 28(4):746-52. PubMed ID: 5649063
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastric acidity response during the intravenous administration of protein hydrolysates.
    STEIGMANN F; ZWEIG M; MEYER KA
    J Lab Clin Med; 1948 Dec; 33(12):1627. PubMed ID: 18100188
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous utilization of partial acid hydrolysates of proteins.
    RISSER WC; SCHENCK JR; FROST DV
    Science; 1946 Mar; 103(2673):362. PubMed ID: 21017957
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous administration of protein hydrolysates].
    MILOSEVIC M
    Med Glas; 1951 Nov; 5(11):258-60. PubMed ID: 14899222
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraportal and intravenous infusion of casein hydrolysate. Comparative studies of the plasma proteins and microscopic liver changes in dogs. Preliminary report.
    HOLM I
    Acta Chir Scand; 1962 Aug; 124():127-33. PubMed ID: 13908489
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphological changes in the liver due to the parenteral administration of casein hydrolysate and aminopeptide].
    Koval' AI; Kryshevich LP
    Vopr Pitan; 1977; (6):10-2. PubMed ID: 414446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.